An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature

Research output: Contribution to journalArticle

Abstract

The term “aristolochic acid nephropathy” (AAN) is used to include any form of toxic interstitial nephropathy that is caused either by ingestion of plants containing aristolochic acids (AA) as part of traditional phytotherapies (formerly known as “Chinese herbs nephropathy”), or by the environmental contaminants in food (Balkan endemic nephropathy). It is frequently associated with urothelial malignancies. Although products containing AA have been banned in most of countries, AAN cases remain regularly reported all over the world. Moreover, AAN incidence is probably highly underestimated given the presence of AA in traditional herbal remedies worldwide and the weak awareness of the disease. During these two past decades, animal models for AAN have been developed to investigate underlying molecular and cellular mechanisms involved in AAN pathogenesis. Indeed, a more-in-depth understanding of these processes is essential to develop therapeutic strategies aimed to reduce the global and underestimated burden of this disease. In this regard, our purpose was to build a broad overview of what is currently known about AAN. To achieve this goal, we aimed to summarize the latest data available about underlying pathophysiological mechanisms leading to AAN development with a particular emphasis on the imbalance between vasoactive factors as well as a focus on the vascular events often not considered in AAN.
LanguageEnglish
JournalInternational Journal of Molecular Sciences
Volume18
Issue number2
DOIs
StatePublished - 29 Jan 2017

Fingerprint

Aristolochic Acids
acids
Acids
Balkan Nephropathy
Phytotherapy
aristolochic acid I
Poisons
ingestion
pathogenesis
Blood Vessels
animal models
Animals
Animal Models
Eating
food
Impurities
contaminants
Food
interstitials
incidence

Keywords

    Cite this

    @article{e1f013d38da44bcfa7177a4d0d6f5725,
    title = "An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature",
    abstract = "The term “aristolochic acid nephropathy” (AAN) is used to include any form of toxic interstitial nephropathy that is caused either by ingestion of plants containing aristolochic acids (AA) as part of traditional phytotherapies (formerly known as “Chinese herbs nephropathy”), or by the environmental contaminants in food (Balkan endemic nephropathy). It is frequently associated with urothelial malignancies. Although products containing AA have been banned in most of countries, AAN cases remain regularly reported all over the world. Moreover, AAN incidence is probably highly underestimated given the presence of AA in traditional herbal remedies worldwide and the weak awareness of the disease. During these two past decades, animal models for AAN have been developed to investigate underlying molecular and cellular mechanisms involved in AAN pathogenesis. Indeed, a more-in-depth understanding of these processes is essential to develop therapeutic strategies aimed to reduce the global and underestimated burden of this disease. In this regard, our purpose was to build a broad overview of what is currently known about AAN. To achieve this goal, we aimed to summarize the latest data available about underlying pathophysiological mechanisms leading to AAN development with a particular emphasis on the imbalance between vasoactive factors as well as a focus on the vascular events often not considered in AAN.",
    keywords = "nephrotoxicity",
    author = "In{\`e}s Jadot and Anne-Emilie Decleves and Jo{\"e}lle Nortier and Nathalie Caron",
    year = "2017",
    month = "1",
    day = "29",
    doi = "10.3390/ijms18020297",
    language = "English",
    volume = "18",
    journal = "International Journal of Molecular Sciences",
    issn = "1661-6596",
    publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
    number = "2",

    }

    TY - JOUR

    T1 - An Integrated View of Aristolochic Acid Nephropathy

    T2 - International Journal of Molecular Sciences

    AU - Jadot,Inès

    AU - Decleves,Anne-Emilie

    AU - Nortier,Joëlle

    AU - Caron,Nathalie

    PY - 2017/1/29

    Y1 - 2017/1/29

    N2 - The term “aristolochic acid nephropathy” (AAN) is used to include any form of toxic interstitial nephropathy that is caused either by ingestion of plants containing aristolochic acids (AA) as part of traditional phytotherapies (formerly known as “Chinese herbs nephropathy”), or by the environmental contaminants in food (Balkan endemic nephropathy). It is frequently associated with urothelial malignancies. Although products containing AA have been banned in most of countries, AAN cases remain regularly reported all over the world. Moreover, AAN incidence is probably highly underestimated given the presence of AA in traditional herbal remedies worldwide and the weak awareness of the disease. During these two past decades, animal models for AAN have been developed to investigate underlying molecular and cellular mechanisms involved in AAN pathogenesis. Indeed, a more-in-depth understanding of these processes is essential to develop therapeutic strategies aimed to reduce the global and underestimated burden of this disease. In this regard, our purpose was to build a broad overview of what is currently known about AAN. To achieve this goal, we aimed to summarize the latest data available about underlying pathophysiological mechanisms leading to AAN development with a particular emphasis on the imbalance between vasoactive factors as well as a focus on the vascular events often not considered in AAN.

    AB - The term “aristolochic acid nephropathy” (AAN) is used to include any form of toxic interstitial nephropathy that is caused either by ingestion of plants containing aristolochic acids (AA) as part of traditional phytotherapies (formerly known as “Chinese herbs nephropathy”), or by the environmental contaminants in food (Balkan endemic nephropathy). It is frequently associated with urothelial malignancies. Although products containing AA have been banned in most of countries, AAN cases remain regularly reported all over the world. Moreover, AAN incidence is probably highly underestimated given the presence of AA in traditional herbal remedies worldwide and the weak awareness of the disease. During these two past decades, animal models for AAN have been developed to investigate underlying molecular and cellular mechanisms involved in AAN pathogenesis. Indeed, a more-in-depth understanding of these processes is essential to develop therapeutic strategies aimed to reduce the global and underestimated burden of this disease. In this regard, our purpose was to build a broad overview of what is currently known about AAN. To achieve this goal, we aimed to summarize the latest data available about underlying pathophysiological mechanisms leading to AAN development with a particular emphasis on the imbalance between vasoactive factors as well as a focus on the vascular events often not considered in AAN.

    KW - nephrotoxicity

    U2 - 10.3390/ijms18020297

    DO - 10.3390/ijms18020297

    M3 - Article

    VL - 18

    JO - International Journal of Molecular Sciences

    JF - International Journal of Molecular Sciences

    SN - 1661-6596

    IS - 2

    ER -